Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001728117-24-000092
Filing Date
2024-11-07
Accepted
2024-11-07 16:01:34
Documents
71
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q goss-20240930.htm   iXBRL 10-Q 1077940
2 EX-31.1 goss-20240930x10qxexx311.htm EX-31.1 10023
3 EX-31.2 goss-20240930x10qxexx312.htm EX-31.2 10050
4 EX-32.1 goss-20240930x10qxexx321.htm EX-32.1 5013
5 EX-32.2 goss-20240930x10qxexx322.htm EX-32.2 5052
  Complete submission text file 0001728117-24-000092.txt   6747565

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20240930.xsd EX-101.SCH 53420
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT goss-20240930_cal.xml EX-101.CAL 73530
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT goss-20240930_def.xml EX-101.DEF 281731
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20240930_lab.xml EX-101.LAB 699194
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20240930_pre.xml EX-101.PRE 474661
74 EXTRACTED XBRL INSTANCE DOCUMENT goss-20240930_htm.xml XML 830924
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38796 | Film No.: 241435386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)